Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Oruka Therapeutics Inc (NASDAQ: ORKA) was $9.56 for the day, down -6.82% from the previous closing price of $10.26. In other words, the price has decreased by -$6.82 from its previous closing price. On the day, 0.71 million shares were traded. ORKA stock price reached its highest trading level at $10.19 during the session, while it also had its lowest trading level at $8.95.
Ratios:
Our analysis of ORKA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 28.89 and its Current Ratio is at 28.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 04, 2025, initiated with a Outperform rating and assigned the stock a target price of $20.
On October 11, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $49.
On October 07, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $45.H.C. Wainwright initiated its Buy rating on October 07, 2024, with a $45 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 14 ’25 when Venrock Healthcare Capital Par bought 88,794 shares for $11.44 per share. The transaction valued at 1,015,803 led to the insider holds 4,148,428 shares of the business.
Venrock Healthcare Capital Par bought 14,950 shares of ORKA for $173,868 on Feb 13 ’25. The 10% Owner now owns 4,059,634 shares after completing the transaction at $11.63 per share. On Feb 12 ’25, another insider, Venrock Healthcare Capital Par, who serves as the 10% Owner of the company, bought 8,971 shares for $11.86 each. As a result, the insider paid 106,396 and bolstered with 4,044,684 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORKA now has a Market Capitalization of 357931200 and an Enterprise Value of -13817724.
Stock Price History:
The Beta on a monthly basis for ORKA is 0.46, which has changed by -0.7548718 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, ORKA has reached a high of $33.00, while it has fallen to a 52-week low of $9.44. The 50-Day Moving Average of the stock is -17.04%, while the 200-Day Moving Average is calculated to be -52.49%.
Shares Statistics:
ORKA traded an average of 264.16K shares per day over the past three months and 248080 shares per day over the past ten days. A total of 37.44M shares are outstanding, with a floating share count of 31.69M. Insiders hold about 15.35% of the company’s shares, while institutions hold 71.87% stake in the company. Shares short for ORKA as of 1741910400 were 1546604 with a Short Ratio of 5.85, compared to 1739491200 on 1761997. Therefore, it implies a Short% of Shares Outstanding of 1546604 and a Short% of Float of 6.6000000000000005.
